HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMPACT THERAP-B

37.000

+0.3000.82%

Volume:230.40K

Turnover:8.46M

Market Cap:10.45B

PE:-25.68

High:38.460

Open:36.600

Low:36.100

Close:36.700

52wk High:47.980

52wk Low:28.200

Shares:282.46M

HK Float Shares:282.46M

Volume Ratio:0.58

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.441

ROE:--

ROA:-40.35%

PB:-9.42

PE(LYR):-25.68

PS:235.92

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

IMPACT Therapeutics boosts share capital by 2.30 % through full over-allotment option exercise

Bulletin Express

IMPACT THERAP-B Issues 6.3 Million H Shares Upon Full Exercise of Over-Allotment Option

IMPACT Therapeutics Concludes Stabilization; 6.30 Million H Shares Allotted at HK$20.10 Each

Bulletin Express

IMPACT THERAP-B Concludes Stabilization Period with Full Exercise of Over-Allotment Option

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/07630"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"IMPACT THERAP-B","latestPrice":37,"timestamp":1781165308322,"preClose":36.7,"halted":0,"volume":230400,"delay":0,"changeRate":0.008174386920980848,"floatShares":282461530,"shares":282461530,"eps":-1.440772,"marketStatus":"Not Yet Opened","change":0.3,"latestTime":"06-11 16:08:28","open":36.6,"high":38.46,"low":36.1,"amount":8459444,"amplitude":0.064305,"askPrice":37.08,"askSize":1400,"bidPrice":36.14,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.16,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1781227800000},"marketStatusCode":0,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":36.7,"openAndCloseTimeList":[[1781141400000,1781150400000],[1781154000000,1781164800000]],"volumeRatio":0.575424575582659,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":282461530,"roa":"-40.35%","roe":"--","lyrEps":-1.440772,"volumeRatio":0.575424575582659,"shares":282461530,"dividePrice":0,"high":38.46,"amplitude":0.064305,"preClose":36.7,"low":36.1,"week52Low":28.2,"pbRate":"-9.42","psRate":"235.92","week52High":47.98,"institutionHeld":0,"latestPrice":37,"committee":-0.75,"eps":-1.440772,"divideRate":0,"volume":230400,"delay":0,"ttmEps":-1.16,"open":36.6,"prevYearClose":20.1,"prevWeekClose":37.02,"prevMonthClose":39.9,"prevQuarterClose":20.1,"fiveDayClose":40.08,"twentyDayClose":41.86,"sixtyDayClose":20.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07630\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07630\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07630","date":"2026-06-10","current":-31.896552,"percent":0.85,"low":-34.323153,"twenty":-32.344912,"median":-30.958502,"eighty":-29.849738,"high":-16.800385,"avg":-30.407128,"sd":3.543955,"marketCap":10135260271},"quantilePoints":[{"date":"2026-05-15","current":-32.36994,"twenty":-32.973318,"median":-32.357426,"eighty":-26.127101,"marketCap":11057651805},{"date":"2026-05-22","current":-30.548005,"twenty":-32.354923,"median":-30.958502,"eighty":-28.393426,"marketCap":10411425401},{"date":"2026-05-29","current":-32.218614,"twenty":-32.294393,"median":-30.958502,"eighty":-30.148817,"marketCap":11018988687},{"date":"2026-06-05","current":-29.849738,"twenty":-32.359929,"median":-31.257987,"eighty":-30.148817,"marketCap":10223633112},{"date":"2026-06-10","current":-29.609087,"twenty":-32.344912,"median":-30.958502,"eighty":-29.849738,"marketCap":10135260271}],"updateTime":1781210326613},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1157701649","title":"IMPACT Therapeutics boosts share capital by 2.30 % through full over-allotment option exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=1157701649","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157701649?lang=en_us&edition=fundamental","pubTime":"2026-06-11 06:23","pubTimestamp":1781130203,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics, Inc. (IMPACT THERAP-B) reported that the joint global coordinators fully exercised the over-allotment option on 10 June 2026, resulting in the issuance and allotment of 6.30...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150770934","title":"IMPACT THERAP-B Issues 6.3 Million H Shares Upon Full Exercise of Over-Allotment Option","url":"https://stock-news.laohu8.com/highlight/detail?id=1150770934","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150770934?lang=en_us&edition=fundamental","pubTime":"2026-06-11 06:16","pubTimestamp":1781129774,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (HKEX: 07630) has announced that on June 10, 2026, it issued and allotted 6.2964 million H shares as a result of the full exercise of the over-allotment option.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179114095","title":"IMPACT Therapeutics Concludes Stabilization; 6.30 Million H Shares Allotted at HK$20.10 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1179114095","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179114095?lang=en_us&edition=fundamental","pubTime":"2026-06-08 17:03","pubTimestamp":1780909380,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics, Inc. (IMPACT Therapeutics) announced the completion of its post-listing stabilization period on 7 June 2026, exactly 30 days after the close of the Hong Kong Public Offering....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132981482","title":"IMPACT THERAP-B Concludes Stabilization Period with Full Exercise of Over-Allotment Option","url":"https://stock-news.laohu8.com/highlight/detail?id=1132981482","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132981482?lang=en_us&edition=fundamental","pubTime":"2026-06-08 16:56","pubTimestamp":1780909011,"startTime":"0","endTime":"0","summary":"The stabilization period relating to the company's global offering concluded on Sunday, June 7, 2026, which is the 30th day after the deadline for submitting Hong Kong public offering...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/07630\",params:#limit:6,delay:false,,,undefined,":[]}}